Document is current

Article History

Received: 19 December 2025

Accepted: 28 February 2026

First Online: 16 March 2026

Declarations

:

: The study was conducted in compliance with the Helsinki Declaration and informed consent to participate was obtained from all of the participants in the study. The study protocol was approved by the Ethics Committee of Tampere University Hospital (approval number R15186).

: Not applicable.

: PS reports fees for lectures and advisory board meetings from Astra Zeneca, Chiesi, GSK, Boehringer Ingelheim and Sanofi. JP reports fees for lectures from GSK. PJ and IV has nothing to disclose. HK reports fees for lectures and advisory board meetings from AstraZeneca, Boehringer-Ingelheim, Covis Pharma, GSK, Orion Pharma and Sanofi. JK report fees for lectures and advisory board meetings from AstraZeneca, Boehringer Ingelheim, Chiesi, GSK, Sanofi and Orion Pharma. LL report fees for lectures and advisory board meetings from ALK, AstraZeneca, Berlin Chemie, Boehringer Ingelheim, Chiesi, GSK, Menarini, Novartis, Sanofi and Orion Pharma.